pimobendan has been researched along with thromboxanes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eisert, WG; Eldor, A; Fuks, Z; Muller, TH; Vlodavsky, I | 1 |
| Fiakpui, NN; Green, HW; Hogan, DF; Magee, AN; Sederquist, KA; Shipley, EA | 1 |
2 other study(ies) available for pimobendan and thromboxanes
| Article | Year |
|---|---|
Different effects of aspirin, dipyridamole and UD-CG 115 on platelet activation in a model of vascular injury: studies with extracellular matrix covered with endothelial cells.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Blood Platelets; Cattle; Cells, Cultured; Dipyridamole; Endothelium; Epoprostenol; Extracellular Matrix; Humans; Models, Biological; Platelet Aggregation; Pyridazines; Thromboxanes | 1986 |
In vitro effect of pimobendan on platelet aggregation in dogs.
Topics: Animals; Area Under Curve; Cardiotonic Agents; Dogs; Female; Male; Platelet Aggregation; Pyridazines; Thromboxanes | 2013 |